| Thursday, August 19, 2021 |
| First 3D-bioprinting of entire active tumor |
AUGUST 18, 2021
by Tel-Aviv University
Microscopic image of the 3D-bioprinted glioblastoma model. The bioprinted blood vessels are covered with endothelial cells (red) and pericytes (cyan). The blood vessels are surrounded with a brain-mimicking tissue composed of gliblastoma cells (blue) and the brain microenvironment cells (green). Different drugs or cells can b ...more
|
|
|
|
|
|
| Thursday, August 19, 2021 |
| New treatment method for breast cancer with less side effects |
AUGUST 18, 2021
by Karolinska Institutet
Thomas Hatschek, associate professor at the department of Oncology-Pathology, together with colleagues, has recently published an article in JAMA Oncology showing that a new treatment for breast cancer with an antibody linked to a cytotoxic drug is as good as the previous combination, but with fewer side effects.
The dev ...more
|
|
|
|
|
|
|
|
| Thursday, August 19, 2021 |
| Experimental drug that boosts immunotherapy shows promise in bladder cancer study |
AUGUST 16, 2021
by UNC Lineberger Comprehensive Cancer Center
Experimental drug that boosts immunotherapy shows promise in bladder cancer study
http://www.scientificanimations.com/, CC BY-SA 4.0
A new study in mice found that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission. This approach shows suc ...more
|
|
|
|
|
|
| Thursday, August 19, 2021 |
| Wearable temperature sensor provides early warning for complications in cancer patients |
AUGUST 13, 2021
by University of Michigan
A simple, wearable temperature sensor was able to detect dangerous complications in hospitalized cancer patients hours earlier than routine monitoring, a team from the University of Michigan Rogel Cancer Center found.
The device, which takes readings every two minutes and wirelessly transmits them to the cloud, was able t ...more
|
|
|
|
|
|
| Thursday, August 19, 2021 |
| New advances in treating non-small cell lung cancer |
AUGUST 12, 2021
by Yale University
A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer (NSCLC). The goal of the study is to provide views on how basic science advances will impact clinical research areas to help influence how NSCLC will be managed over the coming decade. The perspective is ...more
|
|
|
|
|
|
| Thursday, August 19, 2021 |
| Analysis shows how a rare population of cancer cells contributes to disease relapse |
AUGUST 11, 2021
by Allessandra Dicorato, Harvard Medical School
Most cancer-related deaths occur not from the first tumor to arise in a patient but from cancers that reappear months or years after treatment.
Scientists think that a group of rare cancer cells, called persister cells, might contribute to such recurrence. Persister cells account for only a fractio ...more
|
|
|
|
|
|
| Thursday, August 19, 2021 |
| Hunting Down The Mutations That Cause Cancer Drug Resistance |
AUGUST 10, 2021
Hunting down the mutations that cause cancer drug resistance
by UT Southwestern Medical Center
Using a virus to purposely mutate genes that produce cancer-driving proteins could shed light on the resistance that inevitably develops to cancer drugs that target them, a new study led by UT Southwestern scientists suggests. The findings, published onlin ...more
|
|
|
|
|
|
|
|
| Thursday, August 19, 2021 |
| Artificial Intelligence aids in discovery of new prognostic biomarkers for breast cancer |
AUGUST 6, 2021
by Case Western Reserve University
Artificial Intelligence aids in discovery of new prognostic biomarkers for breast cancer
Images of the collagen network in breast tissue samples. Credit: Case Western Reserve University
Scientists at Case Western Reserve University have used Artificial Intelligence (AI) to identify new biomarkers for breast cancer ...more
|
|
|
|
|
|
| Thursday, August 19, 2021 |
| Vitamin D reduces the need for opioids in palliative cancer |
AUGUST 5, 2021
by Karolinska Institutet
Vitamin D reduces the need for opioids in palliative cancer
Main analysis: forest plots with beta coefficient and 95% CI over the opioid use in the ‘Palliative-D’ study. The intention-to-treat (ITT) analyses include all 244 randomized patients, and the Per Protocol (PP) analysis is based on the 150 patients that completed t ...more
|
|
|
|
|
|
| Wednesday, August 4, 2021 |
| Frequent consumption of peanuts by cancer patients may increase risk of cancer spread |
AUGUST 4, 2021
by University of Liverpool
A study by University of Liverpool researchers has identified new factors accompanying previous findings that frequent consumption of peanuts by cancer patients could increase risk of cancer spread.
The study, published in Carcinogenesis shows that Peanut agglutinin (PNA) – a carbohydrate-binding protein that rapidly ...more
|
|
|
|
|
|
| Wednesday, August 4, 2021 |
| Statins may improve survival for triple-negative breast cancer patients |
AUGUST 3, 2021
by University of Texas M. D. Anderson Cancer Center
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minima ...more
|
|
|
|
|
|
| Wednesday, August 4, 2021 |
| Combined therapy shows promise for chronic lymphocytic leukemia |
AUGUST 2, 2021
by Melissa Rohman, Northwestern University
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia (CLL), according to a Northwestern Medicine clinical trial published in Blood.
The findings support the practice of fixed-duration therapy ...more
|
|
|
|
|
|
| Wednesday, August 4, 2021 |
| Pretreatment fatigue can mean worse survival outcomes for patients with cancer |
JULY 30, 2021
by National Cancer Institute
Patients with cancer who reported clinically significant fatigue at the start of their treatment had shorter overall survival times and more side effects than patients without fatigue. Those are the findings of a new analysis of patients who took part in four clinical trials testing treatments for lung cancer or prostate ca ...more
|
|
|
|
|
|
| Wednesday, August 4, 2021 |
| New cancer therapies that reduce the risk of heart damage |
JULY 29, 2021
by Skylar Cuevas, Vanderbilt University
With modern-day cancer therapeutics presenting adverse side effects to heart health, scientists are studying methods to attack cancer cells without the risk of damaging the heart. Researchers Steven Townsend, associate professor of chemistry, and Neil Osheroff, John Coniglio Professor of Biochemistry and professo ...more
|
|
|
|
|
|
| Wednesday, August 4, 2021 |
| Tiny bubbles used to treat common childhood cancer |
JULY 28, 2021
by University College London
Researchers at UCL have developed a new way to deliver drugs that can shut down cancer-promoting mutations in neuroblastoma. The findings in mice, show the method, which uses tiny bubbles to deliver therapies directly to tumor cells, reduced tumor growth and improved survival.
Neuroblastoma is the most common solid t ...more
|
|
|
|
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| argeting radiation resistance: Why some tumors are so stubborn |
MAY 12, 2021
by Jerry Grillo, Georgia Institute of Technology
Radiation therapy has been—and will be—a cornerstone of cancer treatment for good reason: It works.
Mostly.
Currently, more than half of cancer patients receive radiation as part of their treatment. But 20 percent of them, give or take, will find that they need different options because their tumors ...more
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| New therapy shortens treatment for HPV-related cancers of the tonsils, tongue |
MAY 11, 2021
by From Mayo Clinic News Network, Mayo Clinic News Network
Patients with HPV-related oropharyngeal cancer who undergo surgery and are treated with chemotherapy, may be able to forgo significant radiation therapy without increasing the risk of their cancer spreading, according to the results of a clinical trial led by researchers at Mayo Clinic.
"We ...more
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| Esophageal cancers resurrect ancient retroviruses hidden in our genome |
MAY 10, 2021
by Columbia University Irving Medical Center
Scientists have discovered that many esophageal cancers turn on ancient viral DNA that was embedded in our genome hundreds of millions of years ago.
"It was surprising," says Adam Bass, MD, the Herbert and Florence Irving Professor of Medicine at Columbia University Vagelos College of Physicians and Surg ...more
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| Switch of breast tumors to HER2-low in recurrence may provide greater therapeutic options |
MAY 8, 2021
by European Society for Medical Oncology
The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low tumours.
The first study of its kind exploring how breas ...more
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| New saliva oral and throat cancer diagnosis test receives FDA approval |
MAY 7, 2021
by Rose Trapnell, Queensland University of Technology
New saliva oral and throat cancer diagnosis test receives FDA approval
A QUT researcher's identification of saliva as an early detection liquid biopsy for oral and throat cancer has been realized by the development and commercialisation of a diagnostic device by US-based biotech company Viome.
...more
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| Sugar-sweetened drinks linked to increased risk of colorectal cancer in women under 50 |
MAY 6, 2021
by Washington University School of Medicine
Colorectal cancer diagnoses have increased among people under age 50 in recent years and researchers are seeking reasons why. A new study led by Washington University School of Medicine in St. Louis has found a link between drinking sugar-sweetened beverages and an increased risk of developing colorectal cancer ...more
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| Artificial intelligence system may improve diagnosis of complicated metastatic cancers |
MAY 5, 2021
by Brigham and Women's Hospital
To improve diagnosis for patients with complex metastatic cancers, especially those in low-resource settings, researchers from the Mahmood Lab at the Brigham and Women's Hospital developed an artificial intelligence (AI) system that uses routinely acquired histology slides to accurately find the origins of metastatic tumor ...more
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| Many Americans wrong about Sun's skin cancer dangers: Poll |
MAY 4, 2021
(HealthDay)—You might think everybody knows how to protect themselves from the sun's harmful rays, but a new survey reveals that one-third of Americans lack a basic understanding of sun safety and skin cancer.
That's the surprising takeaway from an American Academy of Dermatology (AAD) survey of 1,000 U.S. adults.
Fifty-three percent of respondent ...more
|
|
|
|
|
|
| Thursday, May 13, 2021 |
| Obamacare gave more breast cancer survivors access to breast reconstruction |
MAY 3, 2021
by SOURCE: American Society of Breast Surgeons
(HealthDay)—Breast reconstruction rates rose significantly among Black women after Obamacare expanded access to Medicaid, a new study says.
It also found a large increase in reconstruction rates among women with lower income and education levels.
The findings suggest "that Medicaid expansion was high ...more
|
|
|
|
|
|
| Tuesday, February 23, 2021 |
| Acid reflux disease may increase risk of cancers of the larynx and esophagu |
FEBRUARY 22, 2021s
by Wiley
Results from a large prospective study indicate that gastroesophageal reflux disease (GERD), which also causes heartburn symptoms, is linked with higher risks of various cancers of the larynx (or voice box) and esophagus. The study is published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
GERD, a ga ...more
|
|
|
|
|
|
| Tuesday, February 23, 2021 |
| Turbocharging the killing power of immune cells against cancer |
FEBRUARY 19, 2021
by University Health Network
Creating "super soldiers" of specific white blood cells to boost an anti-tumor response has been shown in a series of elegant experiments by Princess Margaret researchers.
Research led by Ph.D. candidate Helen Loo Yau, Post-doctoral fellow Dr. Emma Bell and Senior Scientist Dr. Daniel D. De Carvalho describes a DNA ...more
|
|
|
|
|
|
|